Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference Transcript
Okay. We'll go ahead and get started. So welcome to the afternoon session of the 2020 JPMorgan Health Care Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tess Romero from the team. Our next presenting company is Kiniksa. And presenting on behalf of the company, we have CEO, Sanj Patel. Sanj?
Thanks, Anupam. Good afternoon. It's great to be here. This is actually the 10th time I have had the opportunity of presenting at this conference. And as usual, I want to thank JPMorgan and Anupam, for hosting us today. We have a lot to go through. So let's get started.
I'm going to start with an overview of our corporate strategy, review our pipeline and also the multiple clinical data readouts that we have coming up this year. First, please note that I will be making forward-looking statements today that are subject to risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |